SCHEMBL30217397

SCHEMBL30217397

CC(C(=O)NN)c1cccc(Br)c1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.43
GAA P10253 1/20 0.43
HTT P42858 2/20 0.37
OGG1 O15527 1/20 0.36
CTSD P07339 1/20 0.35
F2R P25116 1/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
CES2 O00748 1/20 0.33
CES1 P23141 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
MMP1 P03956 1/20 0.33
MMP2 P08253 1/20 0.33
MMP3 P08254 1/20 0.33
MMP9 P14780 1/20 0.33
MMP8 P22894 1/20 0.33
MMP12 P39900 1/20 0.33
MMP13 P45452 1/20 0.33
MMP14 P50281 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29237320 1.00 ALDH1A1 (0.43) ALDH1A1GAAHTTOGG1CTSD
SCHEMBL27821004 0.82 HTT (0.38) HTTCES2CES1CYP2C9CYP2C19
SCHEMBL30967948 0.80 PTGS2 (0.44) ALDH1A1HTTMEN1KMT2ACES2
SCHEMBL29237497 0.80 HTT (0.37) HTTCES2CES1CYP2C9CYP2C19
SCHEMBL30967888 0.80 HTT (0.37) HTTCES2CES1CYP2C9CYP2C19
SCHEMBL29237654 0.80 PTGS2 (0.44) ALDH1A1HTTMEN1KMT2ACES2
SCHEMBL30838570 0.80 ALDH1A1 (0.55) ALDH1A1GAACTSDMEN1KMT2A
SCHEMBL31455895 0.79 PTGS1 (0.40) ALDH1A1HTTMEN1KMT2ACYP2C9
SCHEMBL31176944 0.79 HTT (0.40) ALDH1A1HTTCES2CES1CYP2C9
SCHEMBL31176743 0.76 HTT (0.38) ALDH1A1HTTMEN1KMT2ACES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240279220-A1 INDOLE COMPOUNDS AND METHODS OF USE SIONNA THERAPEUTICS INC. 2024-08-22 US disclosed
EP-4396179-A1 INDOLE COMPOUNDS AND METHODS OF USE GENZYME CORPORATION (US) 2024-07-10 EP disclosed
CN-118201919-A Indole compounds and methods of use 健赞公司 2024-06-14 CN disclosed
WO-2023034992-A1 INDOLE COMPOUNDS AND METHODS OF USE GENZYME CORPORATION (US) 2023-03-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240279220-A1 INDOLE COMPOUNDS AND METHODS OF USE CFTR, INMT, IDO1 ALDH1A1 784/4885GAA 1144/4885HTT 553/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.